Abstract
In searching for a safe and effective compound to be used as a chemoprotective agent to prevent toxicity of the anthracyclin doxorubicin to renal cells, the present study demonstrated that plaunotol, a purified acyclic diterpene from Croton stellatopilosus Ohba, showed potential protection against doxorubicin-induced cell death in human proximal tubule cells. Treatment of renal cells with doxorubicin resulted in a significant decrease in viability of the cells, and we next proved that such toxicity was mainly due to apoptotic cell death. Pretreatment of the cells with plaunotol for at least 9 h prior to doxorubicin exposure improved the cells’ survival. Plaunotol was shown to up-regulate the anti-apoptotic myeloid cell leukemia-1 (Mcl-1) level whereas it had no effect on the Bcl-2 level. The reduction in Mcl-1 after doxorubicin treatment was shown to be closely associated with the toxic action of the drug, and the increase in Mcl-1 induced by plaunotol pretreatment was able to prevent cell death induced by doxorubicin. Furthermore, the protective effect of plaunotol was evaluated in human lung and melanoma cells. Results indicated that plaunotol had no significantly protective effect in human lung carcinoma cells, whereas it sensitized melanoma cells to drug-induced cell death.
Similar content being viewed by others
References
Lown JW (1993) Anthracycline and anthraquinone anticancer agents: current status and recent developments. Pharmacol Ther 60:185–214
Mansour MA, El-Kashef HA, Al-Shabanah OA (1999) Effect of captopril on doxorubicin-induced nephrotoxicity in normal rats. Pharmacol Res 39:233–237
Saad SY, Najjar TA, Al-Rikabi AC (2001) The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol Res 43:211–218. doi:10.1006/phrs.2000.0769
Singal PK, Iliskovic N (1998) Doxorubicin-induced cardiomyopathy. N Engl J Med 339:900–905
Burke JF Jr, Laucius JF, Brodovsky HS, Soriano RZ (1977) Doxorubicin hydrochloride-associated renal failure. Arch Intern Med 137:385–388
Cheng CY, Sue YM, Chen CH, Hou CC, Chan P, Chu YL, Chen TH, Hsu YH (2006) Tetramethylpyrazine attenuates adriamycin-induced apoptotic injury in rat renal tubular cells NRK-52E. Planta Med 72:888–893. doi:10.1055/s-2006-946695
Ueda N, Shah SV (2000) Tubular cell damage in acute renal failure-apoptosis, necrosis, or both. Nephrol Dial Transplant 15:318–323
Zhang J, Clark JR Jr, Herman EH, Ferrans VJ (1996) Doxorubicin-induced apoptosis in spontaneously hypertensive rats: differential effects in heart, kidney and intestine, and inhibition by ICRF-187. J Mol Cell Cardiol 28:1931–1943
Boonsanit D, Kanchanapangka S, Buranakarl C (2006) l-Carnitine ameliorates doxorubicin-induced nephrotic syndrome in rats. Nephrology (Carlton) 11:313–320. doi:10.1111/J.1440-1797.2006.00592.X
Boutabet K, Kebsa W, Alyane M, Lahouel M (2010) Polyphenolic fraction of Algerian propolis protects rat kidney against acute oxidative stress induced by doxorubicin. Indian J Nephrol 21:101–106
Chen CH, Lin H, Hsu YH, Sue YM, Cheng TH, Chan P, Chen TH (2006) The protective effect of prostacyclin on adriamycin-induced apoptosis in rat renal tubular cells. Eur J Pharmacol 529:8–15. doi:10.1016/J.EJPHAR.2005.10.057
Lebrecht D, Setzer B, Rohrbach R, Walker UA (2004) Mitochondrial DNA and its respiratory chain products are defective in doxorubicin nephrosis. Nephrol Dial Transplant 19:329–336. doi:10.1093/ndt/gfg564
Akgul C (2009) Mcl-1 is a potential therapeutic target in multiple types of cancer. Cell Mol Life Sci 66:1326–1336. doi:10.1007/s00018-008-8637-6
Michels J, Johnson PWM, Packham G (2005) Molecules in focus––Mcl-1. Int J Biochem Cell Biol 37:267–271. doi:10.1016/J.BIOCEL.2004.04.007
Thomas LW, Lam C, Edwards SW (2010) Mcl-1; the molecular regulation of protein function. FEBS Lett 584:2981–2989. doi:10.1016/j.febslet.2010.05.061
Katoh O, Takahashi T, Oguri T, Kuramoto K, Mihara K, Kobayashi M, Hirata S, Watanabe H (1998) Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor. Cancer Res 58:5565–5569
Lestini BJ, Goldsmith KC, Fluchel MN, Liu X, Chen NL, Goyal B, Pawel BR, Hogarty MD (2009) Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists. Cancer Biol Ther 8:1587–1595
Lopez-Royuela N, Perez-Galan P, Galan-Malo P, Yuste VJ, Anel A, Susin SA, Naval J, Marzo I (2010) Different contribution of BH3-only proteins and caspases to doxorubicin-induced apoptosis in p53-deficient leukemia cells. Biochem Pharmacol 79:1746–1758. doi:10.1016/J.BCP.2010.02.010
Wirth T, Kuhnel F, Fleischmann-Mundt B, Woller N, Djojosubroto M, Rudolph KL, Manns M, Zender L, Kubicka S (2005) Telomerase-dependent virotherapy overcomes resistance of hepatocellular carcinomas against chemotherapy and tumor necrosis factor-related apoptosis-inducing ligand by elimination of Mcl-1. Cancer Res 65:7393–7402. doi:10.1158/0008-5472.CAN-04-3664
Krajewski S, Bodrug S, Krajewska M, Shabaik A, Gascoyne R, Berean K, Reed JC (1995) Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am J Pathol 146:1309–1319
Paduch R, Kandefer-Szerszen M, Trytek M, Fiedurek J (2007) Terpenes: substances useful in human healthcare. Arch Immunol Ther Exp (Warsz) 55:315–327. doi:10.1007/s00005-007-0039-1
Higuchi K, Watanabe T, Tanigawa T, Shiba M, Tominaga K, Fujiwara Y, Oshitani N, Arakawa T (2007) Are gastroprotective drugs useful for gastric ulcer healing: re-evaluation using current ICH E9 guidelines. Inflammopharmacology 15:18–21. doi:10.1007/s10787-006-0300-y
Yamada J, Kawai K, Tsuno NH, Kitayama J, Tsuchiya T, Yoneyama S, Asakage M, Okaji Y, Takahashi K, Nagawa H (2007) Plaunotol induces apoptosis of gastric cancer cells. Planta Med 73:1068–1073. doi:10.1055/s-2007-981578
Yoshikawa N, Yamada J, Tsuno NH, Okaji Y, Kawai K, Tsuchiya T, Yoneyama S, Tanaka J, Shuno Y, Nishikawa T, Nagawa H, Oshima N, Takahashi K (2009) Plaunotol and geranylgeraniol induce caspase-mediated apoptosis in colon cancer. J Surg Res 153:246–253. doi:10.1016/J.JSS.2008.04.021
Dash R, Azab B, Quinn BA, Shen X, Wang XY, Das SK, Rahmani M, Wei J, Hedvat M, Dent P, Dmitriev IP, Curiel DT, Grant S, Wu B, Stebbins JL, Pellecchia M, Reed JC, Sarkar D, Fisher PB (2011) Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity. Proc Natl Acad Sci USA 108:8785–8790. doi:10.1073/pnas.1100769108
Dash R, Richards JE, Su ZZ, Bhutia SK, Azab B, Rahmani M, Dasmahapatra G, Yacoub A, Dent P, Dmitriev IP, Curiel DT, Grant S, Pellecchia M, Reed JC, Sarkar D, Fisher PB (2010) Mechanism by which Mcl-1 regulates cancer-specific apoptosis triggered by mda-7/IL-24, an IL-10-related cytokine. Cancer Res 70:5034–5045. doi:10.1158/0008-5472.CAN-10-0563
Chen W, Bai L, Wang X, Xu S, Belinsky SA, Lin Y (2010) Acquired activation of the Akt/cyclooxygenase-2/Mcl-1 pathway renders lung cancer cells resistant to apoptosis. Mol Pharmacol 77:416–423. doi:10.1124/mol.109.061226
Chetoui N, Sylla K, Gagnon-Houde JV, Alcaide-Loridan C, Charron D, Al-Daccak R, Aoudjit F (2008) Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis. Mol Cancer Res 6:42–52. doi:10.1158/1541-7786.MCR-07-0080
Khodadoust MS, Verhaegen M, Kappes F, Riveiro-Falkenbach E, Cigudosa JC, Kim DS, Chinnaiyan AM, Markovitz DM, Soengas MS (2009) Melanoma proliferation and chemoresistance controlled by the DEK oncogene. Cancer Res 69:6405–6413. doi:10.1158/0008-5472.CAN-09-1063
Wang X, Chen W, Zeng W, Bai L, Tesfaigzi Y, Belinsky SA, Lin Y (2008) Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells. Mol Cancer Ther 7:1156–1163. doi:10.1158/1535-7163.MCT-07-2183
Murakami K, Okajima K, Harada N, Isobe H, Liu W, Johno M, Okabe H (1999) Plaunotol prevents indomethacin-induced gastric mucosal injury in rats by inhibiting neutrophil activation. Aliment Pharmacol Ther 13:521–530
Ohta Y, Kamiya Y, Imai Y, Arisawa T, Nakano H (2005) Plaunotol prevents the progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats. Pharmacology 74:182–192. doi:10.1159/000085388
Burlacu A (2003) Regulation of apoptosis by Bcl-2 family proteins. J Cell Mol Med 7:249–257. doi:10.1111/j.1582-4934.2003.tb00225.x
Chipuk JE, Fisher JC, Dillon CP, Kriwacki RW, Kuwana T, Green DR (2008) Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins. Proc Natl Acad Sci USA 105:20327–20332. doi:10.1073/pnas.0808036105
Ola MS, Nawaz M, Ahsan H (2011) Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem 351:41–58. doi:10.1007/s11010-010-0709-x
Youle RJ, Strasser A (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9:47–59. doi:10.1038/NRM2308
Liu L, Yang C, Herzog C, Seth R, Kaushal GP (2010) Proteasome inhibitors prevent cisplatin-induced mitochondrial release of apoptosis-inducing factor and markedly ameliorate cisplatin nephrotoxicity. Biochem Pharmacol 79:137–146. doi:10.1016/j.bcp.2009.08.015
Ou YC, Yang CR, Cheng CL, Li JR, Raung SL, Hung YY, Chen CJ (2009) Indomethacin causes renal epithelial cell injury involving Mcl-1 down-regulation. Biochem Biophys Res Commun 380:531–536. doi:10.1016/j.bbrc.2009.01.094
Yang C, Kaushal V, Shah SV, Kaushal GP (2007) Mcl-1 is downregulated in cisplatin-induced apoptosis, and proteasome inhibitors restore Mcl-1 and promote survival in renal tubular epithelial cells. Am J Physiol Renal Physiol 292:F1710–F1717. doi:10.1152/AJPRENAL.00505.2006
Gong X, Celsi G, Carlsson K, Norgren S, Chen M (2010) N-Acetylcysteine amide protects renal proximal tubular epithelial cells against iohexol-induced apoptosis by blocking p38 MAPK and iNOS signaling. Am J Nephrol 31:178–188. doi:10.1159/000268161
Lin MT, Lee RC, Yang PC, Ho FM, Kuo ML (2001) Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem 276:48997–49002. doi:10.1074/JBC.M107829200
Fu H, Yabe Y, Asahi K, Hayashi Y, Murata H, Eguchi H, Tsujii M, Tsuji S, Kawano S (2005) (2E,6Z,10E)-7-Hydroxymethyl-3,11,15-trimethyl-2,6,10,14-hexadecatetraen-1-ol (Plaunotol) increases cyclooxygenase-2 expression via nuclear factor kappaB and cyclic AMP response element in rat gastric epithelial cells. Eur J Pharmacol 524:38–43. doi:10.1016/J.EJPHAR.2005.09.044
Acknowledgments
This research was financially supported by The Thailand Research Fund through The Royal Golden Jubilee for PhD program (grant no. 5.Q.CU/50/C.1). The authors thank Mr. Krich Rajprasit for proofreading.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Chaotham, C., De-Eknamkul, W. & Chanvorachote, P. Protective effect of plaunotol against doxorubicin-induced renal cell death. J Nat Med 67, 311–319 (2013). https://doi.org/10.1007/s11418-012-0683-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11418-012-0683-6